{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:55:37Z","timestamp":1781646937092,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2023-12M-C&T-B-110"],"award-info":[{"award-number":["2023-12M-C&T-B-110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary cutaneous diffuse large B-cell lymphoma, leg type(PCDLBCL-LT) is a rare form of lymphoma that originates from the post-germinal center and typically does not express terminal deoxynucleotidyl transferase(TdT), a marker of immunophenotypic immaturity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>\n                      A 73-year-old female presented to our hospital with recurrent nodules on her lower limbs, which had persisted for over five years without systemic involvement, accompanied by a gradual increase in TdT expression. Histology revealed diffuse infiltration of centroblasts and\/or immunoblasts within the dermis and subcutis, with CD20, CD10, BCL2 and c-MYC expression. Fluorescence in situ hybridization (FISH) showed\n                      <jats:italic>MYC<\/jats:italic>\n                      rearrangement without\n                      <jats:italic>BCL2<\/jats:italic>\n                      \/\n                      <jats:italic>BCL6<\/jats:italic>\n                      alterations, corroborating the diagnosis of TdT-positive PCDLBCL-LT. Following six cycle of R-CHOP chemotherapy, the patient achieved complete remission. A follow-up conducted one year showed no tumor recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our case showed that TdT can be expressed in PCDLBCL-LT, and highlight the importance of a comprehensive analysis of clinicopathology and ancillary testing to avoid misdiagnosis. Additionally, the clinical course of TdT-positive PCDLBCL-LT seems remain relatively favorable. However, further research is still needed on this relationship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-026-01768-w","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:34:20Z","timestamp":1775021660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: a case of primary cutaneous diffuse large B-cell lymphoma, leg type with TdT positive in an elderly woman"],"prefix":"10.1186","volume":"21","author":[{"given":"Jingwei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"11","key":"1768_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229\u201353. https:\/\/doi.org\/10.1182\/blood.2022015851.","journal-title":"Blood"},{"key":"1768_CR2","doi-asserted-by":"publisher","unstructured":"Willemze R, Cerroni L, Kempf W et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703\u20131714. Blood. 2019;134(13):1112. https:\/\/doi.org\/10.1182\/blood.2019002852","DOI":"10.1182\/blood.2019002852"},{"issue":"12","key":"1768_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/ddg.13164","volume":"14","author":"JP Nicolay","year":"2016","unstructured":"Nicolay JP, Wobser M. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy. J Dtsch Dermatol Ges. 2016;14(12):1207\u201324. https:\/\/doi.org\/10.1111\/ddg.13164.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"1768_CR4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","volume":"137","author":"S Mareschal","year":"2017","unstructured":"Mareschal S, Pham-Ledard A, Viailly PJ, et al. Identification of somatic mutations in primary cutaneous diffuse large B-Cell Lymphoma, leg type by massive parallel sequencing. J Invest Dermatol. 2017;137(9):1984\u201394. https:\/\/doi.org\/10.1016\/j.jid.2017.04.010.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"1768_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/ajcp\/aqad042","volume":"159","author":"AS Duffield","year":"2023","unstructured":"Duffield AS, Dogan A, Amador C, et al. Progression of follicular lymphoma and related entities: report from the 2021 SH\/EAHP workshop. Am J Clin Pathol. 2023;159(6):572\u201397. https:\/\/doi.org\/10.1093\/ajcp\/aqad042.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"1768_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41379-018-0112-9","volume":"32","author":"CY Ok","year":"2019","unstructured":"Ok CY, Medeiros LJ, Thakral B, et al. High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol. 2019;32(1):48\u201358. https:\/\/doi.org\/10.1038\/s41379-018-0112-9.","journal-title":"Mod Pathol"},{"issue":"11","key":"1768_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328. https:\/\/doi.org\/10.1182\/blood.2022015850.","journal-title":"Blood"},{"issue":"4","key":"1768_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ajcp\/aqae158","volume":"163","author":"EM Moore","year":"2025","unstructured":"Moore EM, Gibson SE. How I diagnose high-grade B-cell lymphoma. Am J Clin Pathol. 2025;163(4):487\u2013500. https:\/\/doi.org\/10.1093\/ajcp\/aqae158.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"1768_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/cup.13795","volume":"48","author":"A Ronchi","year":"2021","unstructured":"Ronchi A, Zito Marino F, Vitiello P, et al. A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse large B-cell lymphoma with immature features or B-cell lymphoblastic lymphoma? J Cutan Pathol. 2021;48(4):535\u201340. https:\/\/doi.org\/10.1111\/cup.13795.","journal-title":"J Cutan Pathol"},{"issue":"5","key":"1768_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/cup.13955","volume":"48","author":"M Endo","year":"2021","unstructured":"Endo M, Ohtsuka M, Watanabe Y, et al. TdT-positive primary cutaneous diffuse large B-cell lymphoma, leg type phenotypically mimicking B-lymphoblastic lymphoma. J Cutan Pathol. 2021;48(5):721\u20134. https:\/\/doi.org\/10.1111\/cup.13955.","journal-title":"J Cutan Pathol"},{"key":"1768_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2021.01.006","volume":"111","author":"M Lucioni","year":"2021","unstructured":"Lucioni M, Pescia C, Bonometti A, et al. Double expressor and double\/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes. Hum Pathol. 2021;111:1\u20139. https:\/\/doi.org\/10.1016\/j.humpath.2021.01.006.","journal-title":"Hum Pathol"},{"issue":"5","key":"1768_CR12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ccr3.2137","volume":"7","author":"M Al Dhafiri","year":"2019","unstructured":"Al Dhafiri M, Sicre de Fontbrune F, Marinho E, et al. Effectiveness of Lenalidomide in relapsed primary cutaneous diffuse large B-cell lymphoma, leg type. Clin Case Rep. 2019;7(5):964\u20137. https:\/\/doi.org\/10.1002\/ccr3.2137.","journal-title":"Clin Case Rep"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01768-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:17:44Z","timestamp":1781644664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01768-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01768-w","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written consent for publication was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}